On 7-Jan-09, representatives of PSS Retail Chapter Committee and Council Members held a focus group forum with HSA. Various practice (especially community practice) and drug regulatory issues were discussed during the session.

Increasingly, more drug products are now derived from blood and blood components, cells, tissues, genetic components, recombinant therapeutic proteins, live or attenuated or dead viruses/bacteria etc. Broadly, we call them “biologics”

In one of the grimmest public health research findings yet, researches have warned that a gene mutation that “almost guarantees the development of heart disease” is carried by 60 million people.

Here are a few brief news related to healthcare & pharmaceutical scenes for your quick update.

• FDA Opens Offices in India 
• Viagra’s Application for Change to OTC Status Withdrawn
● Never Ending IP Tussle with the Generics
• Pfizer to Buy Wyeth in a US$68 Billion Deal

The following jobs/events are currently available. Kindly apply/register directly based on the information provided. Best of luck!